Loading…
Beyond Air, Inc. is projected to decline to $5.69 by 2027, a -10% move from its current price of $6.33. XAIR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $6.02 | $6.32 | $6.64 | -0.13% |
| Aug 6 | $5.89 | $6.31 | $6.77 | -0.26% |
| Aug 7 | $5.79 | $6.30 | $6.87 | -0.40% |
| Aug 8 | $5.70 | $6.30 | $6.95 | -0.53% |
| Aug 9 | $5.63 | $6.29 | $7.03 | -0.66% |
| Aug 10 | $5.56 | $6.28 | $7.09 | -0.79% |
| Aug 11 | $5.50 | $6.27 | $7.15 | -0.92% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.50 | $6.27 | $7.15 | -0.92% |
| Week 2 | $5.16 | $6.21 | $7.48 | -1.83% |
| Week 3 | $4.91 | $6.16 | $7.73 | -2.74% |
| Week 4 | $4.69 | $6.10 | $7.93 | -3.63% |
| Week 5 | $4.51 | $6.04 | $8.10 | -4.52% |
| Week 6 | $4.34 | $5.99 | $8.26 | -5.40% |
| Week 7 | $4.19 | $5.93 | $8.39 | -6.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beyond Air, Inc. is a commercial-stage healthcare company focused on medical devices and biopharmaceuticals. It operates through the Beyond Air, Beyond Cancer, and NeuroNos segments and offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn.
The company is developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. It also develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors, and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions.
The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Beyond Air, Inc. (XAIR) is the asset with current price $5.16 and market cap $3.72M, ranking 5114. The stock trades in the micro-cap space with a current price of $5.16 and a market capitalization of $3.72M, placing it at rank 5114.
The stock’s trajectory over the forecast horizon shows a mixed path, with 2026 holding around the current level and subsequent years projecting both declines and recoveries before stronger long-term upside.
A major floor 94.5% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
The nearest ceiling, 56.4% above — a clean break opens room to run.
A major ceiling 81.8% above — clearing it would confirm fresh momentum.
Key XAIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XAIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.41 | Buy | $5.39 | Buy |
| MA 10 | $5.53 | Buy | $5.23 | Buy |
| MA 20 | $4.37 | Buy | $4.42 | Buy |
| MA 50 | $2.00 | Buy | $2.81 | Buy |
| MA 100 | $1.32 | Buy | $1.96 | Buy |
| MA 200 | $1.33 | Buy | $2.09 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.23 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 30.60 | Neutral |
| Williams %R (14) | -85.98 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -5.97 | Sell |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 14.02 | Buy |
| TRIX (15) | 8.39 | Buy |
| Awesome (5,34) | 2.66 | Buy |
| Ultimate (7,14,28) | 33.66 | Neutral |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 5.39 | Buy |
| ADX (14) | 35.08 | Buy |
| ATR (14) | 0.33 | Info |
The 30-day technical picture shows Neutral sentiment with RSI14 at 30, indicating near oversold conditions. The price is trading below key moving averages, with SMA50 at $8.22 and SMA200 at $19.85. Support is noted at $5.47 and resistance at $9.90, while the 30-day price range stretches from $3.54 to $7.52.
The stock carries high volatility, reflected in an annualized volatility of 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.16 | $6.33 | $7.72 | 0% | Neutral | |
| $4.21 | $5.69 | $8.31 | -10% | Neutral | |
| $3.37 | $4.83 | $7.50 | -24% | Bearish | |
| $3.36 | $5.04 | $8.20 | -20% | Bearish | |
| $3.90 | $6.11 | $10.33 | -3% | Neutral | |
| $4.38 | $7.15 | $12.50 | +13% | Neutral | |
| $4.61 | $7.81 | $14.06 | +23% | Bullish | |
| $3.66 | $6.43 | $11.88 | +2% | Neutral | |
| $3.34 | $6.08 | $11.51 | -4% | Neutral | |
| $3.70 | $6.97 | $13.49 | +10% | Neutral | |
| $4.21 | $9.34 | $19.79 | +48% | Bullish | |
| $7.97 | $17.71 | $40.74 | +180% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.16 | $6.33 | $7.86 | +0.00% |
| September 2026 | $4.98 | $6.02 | $7.59 | -4.84% |
| October 2026 | $4.58 | $5.61 | $7.21 | -6.84% |
| November 2026 | $4.63 | $5.74 | $7.48 | +2.23% |
| December 2026 | $4.67 | $5.84 | $7.72 | +1.88% |
Click any year to see its month-by-month XAIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, XAIR could reach as high as $7.72, with a base case around $6.33 and support toward $5.16 — roughly 0% from $6.33. A consolidation phase looks the most probable path here.
Expect XAIR to range from $4.21 to $8.31 through 2027. The $5.69 average target implies a -10% move from current prices. That is -10% versus the projected 2026 average. Price action looks broadly range-bound.
The XAIR price prediction for 2028 points to an average of $4.83 (low $3.37, high $7.50) — a potential decline of -24% on today's $6.33. Expect choppier, lower action through this leg of the cycle.
In 2029, XAIR is projected to trade between $3.36 and $8.20, averaging $5.04 — a potential decline of -20% from today's $6.33. That is up +4% on the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Beyond Air, Inc.'s 2030 outlook centres on $6.11, within a $3.90 to $10.33 range. That is up +21% on the projected 2029 average. That marks a -3% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, XAIR could reach as high as $12.50, with a base case around $7.15 and support toward $4.38 — roughly +13% from $6.33. Price action looks broadly range-bound.
Expect XAIR to range from $4.61 to $14.06 through 2032. The $7.81 average target implies a +23% move from current prices. That is up +9% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The XAIR price prediction for 2033 points to an average of $6.43 (low $3.66, high $11.88) — a potential gain of +2% on today's $6.33. Price action looks broadly range-bound.
In 2034, XAIR is projected to trade between $3.34 and $11.51, averaging $6.08 — a potential decline of -4% from today's $6.33. That is -5% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Beyond Air, Inc.'s 2035 outlook centres on $6.97, within a $3.70 to $13.49 range. That is up +15% on the projected 2034 average. That marks a +10% change versus current levels. Price action looks broadly range-bound.
By 2040, XAIR could reach as high as $19.79, with a base case around $9.34 and support toward $4.21 — roughly +48% from $6.33. Buyers look set to stay in control over this stretch.
Expect XAIR to range from $7.97 to $40.74 through 2050. The $17.71 average target implies a +180% move from current prices. That is up +90% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XAIR today (≈ 157.977883 XAIR) could be worth
$2,798.14
+$1,798.14 (+180%) by 2050 · US Dollar
Based on the average projected XAIR price of $17.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XAIRwould be worth at today's price.
$1,000 invested in XAIR on Jul 31, 2025 (≈ 335.570468 XAIR) would be worth
$2,124.16
+$1,124.16 (+112.4%) today · 2.12× · US Dollar
Based on a XAIR entry price of $2.98 vs. today's $6.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.16 | $1,226.74 | +22.7% |
| 1 month ago | $0.467 | $13,554.6 | +1255.5% |
| 3 months ago | $0.514 | $12,315.18 | +1131.5% |
| 6 months ago | $1.15 | $5,504.35 | +450.4% |
| 1 year ago | $2.98 | $2,124.16 | +112.4% |
| All time (5.0y) ago | $158.6 | $39.91 | -96.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XAIR forecast.
Our base-case forecast reaches $13.00 around 2050.
Implied market cap at $13.00: $9.37M
Forecasts show volatility across the multi-year horizon. In 2026 the average price is $5.16 with a min of $5.16 and a max of $6.23, and ROI of 0. In 2027 the average price slides to $4.53 with a max of $6.73 and a negative ROI of -12.3, followed by further declines in 2028 (avg $3.84, max $6.08, ROI -25.6) and 2029 (avg $3.83, max $6.38, ROI -25.7).
By 2030 the average rises to $4.96 with a max of $8.59 and ROI -4, then advances to 2031 avg $5.96 (max $10.69, ROI 15.4) and 2032 avg $6.24 (max $11.55, ROI 21). The forecast then projects 2033 avg $5.08 (max $9.67, ROI -1.5), 2034 avg $4.89 (max $9.54, ROI -5.3), and 2035 avg $5.45 (max $10.89, ROI 5.7). In 2040, the average price is forecast at $7.54 (max $16.54, ROI 46.1), and by 2050 the average is $14.26 (max $32.80, ROI 176.4).
These figures are estimates and not guarantees, reflecting potential upside and multi-year volatility.
Tap a question to reveal the answer.
2030 forecast: min $3.07, avg $4.96, max $8.59, ROI -4.
The 2026 forecast shows an average price of $5.16 with ROI 0, but negative ROIs appear in 2027–2029 (-12.3%, -25.6%, -25.7%). Later years show positive ROIs, including 2031 15.4, 2032 21, 2040 46.1, and 2050 176.4, with a potential max of $32.80 in 2050.
Yes. The forecast maximums include 2032 max $11.55 and 2031 max $10.69, with higher maxima later such as 2040 max $16.54 and 2050 max $32.80.
RSI14 is 30 with Neutral sentiment. The 30-day range is $3.54–$7.52, current price is $5.16, with support at $5.47 and resistance at $9.90. The stock is trading below the SMA50 ($8.22) and SMA200 ($19.85); volatility is high (100%).
Current price $5.16 and market cap $3.72M, with rank 5114.
Beyond Air, Inc. Community Discussion
0Share your Beyond Air, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.